AdaptResposne

AdaptResponse Clinical Trial

AdaptResposne [NCT02205359]

Description: The purpose of this clinical study is to test the hypothesis that market released Cardiac Resynchronization Therapy (CRT) devices which contain the AdaptivCRT® (aCRT) algorithm have a superior outcome compared to standard CRT devices in CRT indicated patients with normal atrio-ventricular (AV) conduction and left bundle branch block (LBBB).


Device: aCRT ON; Device: aCRT OFF

Primary Investigator: Chung

Drug/Device Information
The purpose of this clinical study is to test the hypothesis that market released CRT devices which contain the AdaptivCRT (aCRT) algorithm have a superior outcome compared to standard CRT devices
The algorithm is intended to provide ambulatory CRT optimization and allow more physiologic ventricular activation
Greater device longevity in patients with normal AV conduction by reducing unnecessary RV pacing
Randomized in a 1:1 fashion to treatment (aCRT ON) or control (aCRT OFF) group
Medtronic, Inc.